Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 0.39.

  • Gossamer Bio's Equity Ratio fell 35554.83% to 0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39, marking a year-over-year decrease of 35554.83%. This contributed to the annual value of 0.09 for FY2024, which is 5351.81% down from last year.
  • As of Q3 2025, Gossamer Bio's Equity Ratio stood at 0.39, which was down 35554.83% from 0.19 recorded in Q2 2025.
  • Gossamer Bio's 5-year Equity Ratio high stood at 0.3 for Q3 2023, and its period low was 0.39 during Q3 2025.
  • Over the past 4 years, Gossamer Bio's median Equity Ratio value was 0.09 (recorded in 2024), while the average stood at 0.02.
  • Over the last 5 years, Gossamer Bio's Equity Ratio had its largest YoY gain of 35397.85% in 2023, and its largest YoY loss of 41605.76% in 2023.
  • Over the past 4 years, Gossamer Bio's Equity Ratio (Quarter) stood at 0.04 in 2022, then soared by 353.98% to 0.2 in 2023, then tumbled by 53.52% to 0.09 in 2024, then tumbled by 521.51% to 0.39 in 2025.
  • Its last three reported values are 0.39 in Q3 2025, 0.19 for Q2 2025, and 0.02 during Q1 2025.